Studies of polyQ diseases : possible mechanisms of cell death and its prevention by molecular chaperone
PolyQ疾病的研究:细胞死亡的可能机制及其分子伴侣的预防
基本信息
- 批准号:15590915
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We analyzed the apoptotic pathway induced by proteins containing expanded polyQ tract (97 or 24) using cellular model of Spinal and bulbar muscular atrophy (SBMA). When expression plasmids of truncated ARs containing polyQ tracts fused to GFP (tAR24 and tAR97) or polyQ tracts fused to GFP (polyQ24 and polyQ97) were transfected into COS-7 cells, tAR97 and polyQ97, but not tAR24 and polyQ24, induced marked formation of the aggregates and apoptosis in the cells with nuclear aggregates.To examine the apoptotic pathway induced by the polyQ proteins, we next esatablished HeLa-tet cell lines in which expression of PolyQ proteins was regulated by doxycycline. In apoptotic cells, the transition of Bax to mitochondria, release of cytochrome c and activation of caspase 3 were observed concomitantly with the expression of polyQ97. However, unfolded protein response was not observed in these cells. Thus, polyQ97-induced apoptosis seemed to be in part occurred through the mitochondrial pathway via Bax.As the over-expression of heat shock proteins (hsp) suppresses cell death caused by expansion of the polyQ tract, the enhanced expression of hsp may provide an effective therapeutic approach for polyQ diseases. We found that non-steroid anti-inflamatory drugs such as sodium salicylate and indomethacin up-regulated the hsp promoter at 37℃ through the activation of heat shock factor and induced the increased accumulation of hsp in mammalian cells, and also revealed that sodium salicylate and indomethacin suppressed the aggregation of polyQ97 and apoptosis caused by an expanded polyQ tract. Thus, NSAIDs seemed to be used for the protection of cells against deleterious stressors and neurodegenerative diseases.
我们利用脊髓和球性肌萎缩(SBMA)细胞模型,分析了含有扩展多q束(97或24)的蛋白诱导的细胞凋亡途径。将含有与GFP融合的多q束(tAR24和tAR97)或与GFP融合的多q束(polyQ24和polyQ97)的截断ar表达质粒转染到COS-7细胞中,tAR97和polyQ97,而不是tAR24和polyQ24,诱导细胞核聚集的细胞明显形成聚集体和凋亡。为了研究polyQ蛋白诱导的凋亡途径,我们建立了polyQ蛋白表达受强力霉素调控的HeLa-tet细胞系。在凋亡细胞中,随着polyQ97的表达,Bax向线粒体的转移、细胞色素c的释放和caspase 3的激活也随之发生。然而,在这些细胞中未观察到未折叠蛋白的反应。因此,polyq97诱导的细胞凋亡似乎部分是通过线粒体途径通过Bax发生的。由于热休克蛋白(hsp)的过表达可抑制多q通道扩张引起的细胞死亡,因此增强热休克蛋白的表达可能为多q疾病的治疗提供有效的途径。我们发现水杨酸钠和吲哚美辛等非甾体类抗炎药物在37℃时通过激活热休克因子上调hsp启动子,诱导hsp在哺乳动物细胞中积累增加,同时发现水杨酸钠和吲哚美辛抑制polyQ97的聚集和polyQ通道扩张引起的细胞凋亡。因此,非甾体抗炎药似乎可用于保护细胞免受有害压力源和神经退行性疾病的侵害。
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hsp105 not Hsp70 family proteins suppress the aggregation of heat-denatured protein in the presence of ADP.
在 ADP 存在的情况下,Hsp105(而非 Hsp70 家族蛋白)抑制热变性蛋白的聚集。
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Nobuyuki Yamagishi;et al.
- 通讯作者:et al.
Keiichi Ishihara: "Hsp105alpha suppresses the aggregation of truncated androgen receptor with expanded CAG repeats and cell toxicity."J.Biol.Chem.. 278. 25143-25150 (2003)
Keiichi Ishihara:“Hsp105α 通过扩大 CAG 重复序列和细胞毒性抑制截短雄激素受体的聚集。”J.Biol.Chem.. 278. 25143-25150 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hsp105α suppresses Hsc70 chaperone activity by inhibiting Hsc70 ATPase activity
- DOI:10.1074/jbc.m407947200
- 发表时间:2004-10-01
- 期刊:
- 影响因子:4.8
- 作者:Yamagishi, N;Ishihara, K;Hatayama, T
- 通讯作者:Hatayama, T
Screening of Hsp105α-binding proteins using yeast and bacterial two-hybrid systems.
使用酵母和细菌双杂交系统筛选 Hsp105α 结合蛋白。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Matsuda C;Kameyama K;Tagawa K;Ogawa M;Suzuki A;Yamaji S;Okamoto H;Nishino I;Hayashi YK.;Chie Matsuda et al.;Youhei Saito
- 通讯作者:Youhei Saito
Screening of Hsp 105α-binding proteins using yeast and bacterial two-hybrid systems.
使用酵母和细菌双杂交系统筛选 Hsp 105α 结合蛋白。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Youhei Saito;et al.
- 通讯作者:et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HATAYAMA Takumi其他文献
HATAYAMA Takumi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HATAYAMA Takumi', 18)}}的其他基金
Studies on molecular mechanisms of polyglutamine diseases and its treatment with molecular
多聚谷氨酰胺疾病的分子机制及其分子治疗研究
- 批准号:
17590903 - 财政年份:2005
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of molecular chaperones on polyQ-mediated cell death and toxicity using cellular model of SBMA
使用 SBMA 细胞模型研究分子伴侣对 PolyQ 介导的细胞死亡和毒性的影响
- 批准号:
13670674 - 财政年份:2001
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Roles of stress protein hsp105 during mouse embryo development.
应激蛋白 hsp105 在小鼠胚胎发育过程中的作用。
- 批准号:
09670139 - 财政年份:1997
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Generation and characterization of a Cre-Lox regulated transgenic zebrafish model of SBMA
Cre-Lox 调节的 SBMA 转基因斑马鱼模型的生成和表征
- 批准号:
10784254 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Novel repeat associated non-AUG (RAN) proteins in sALS, sFTD and SBMA: shared pathological features and unifying therapeutic opportunities
sALS、sFTD 和 SBMA 中新型重复相关非 AUG (RAN) 蛋白:共同的病理特征和统一的治疗机会
- 批准号:
10420041 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Study of AR transcriptional network in stem cell model of SBMA
SBMA干细胞模型中AR转录网络的研究
- 批准号:
10184227 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Study of AR transcriptional network in stem cell model of SBMA
SBMA干细胞模型中AR转录网络的研究
- 批准号:
10373083 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Study of AR transcriptional network in stem cell model of SBMA
SBMA干细胞模型中AR转录网络的研究
- 批准号:
10581556 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Selective Androgen Receptor Degraders (SARDs) as new therapeutics for spinal and bulbar muscular atrophy (SBMA)
选择性雄激素受体降解剂(SARD)作为脊髓和延髓肌萎缩症(SBMA)的新疗法
- 批准号:
10259452 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Mechanisms of neuromuscular degeneration in SBMA
SBMA 神经肌肉变性的机制
- 批准号:
10471367 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Mechanisms of neuromuscular degeneration in SBMA
SBMA 神经肌肉变性的机制
- 批准号:
10290437 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Mechanisms of neuromuscular degeneration in SBMA
SBMA 神经肌肉变性的机制
- 批准号:
10630945 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Study of SBMA mutant AR transcriptional network in stem cell-derived motor neurons and skeletal muscle
干细胞源性运动神经元和骨骼肌中SBMA突变体AR转录网络的研究
- 批准号:
10599883 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:














{{item.name}}会员




